Given the greatly variable severity of T cell immunodeficiency in the published patient series, treatment of patients with hypomorphic FOXN1 deficiency will need to be individualised according to the extent of functional impairment and consequent clinical severity, with thymic transplantation indicated only for those at the more severe end of the spectrum [123, 124]. Here, FOXN1 is linked to T-cell immunodeficiency.